| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 661 | 636 | 752 | 290 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 661 | 683 | 752 | -1.460 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 6.143 | 2.389 | 5.866 | 5.384 | 45 | 44 | 340 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -5.481 | -1.706 | -5.114 | -6.844 | -45 | -44 | -340 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -5.501 | -1.729 | -5.136 | -6.852 | -45 | -44 | -340 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Batec Biotechnologie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.254 | 10.149 | 5.736 | 453 | 399 | 348 | 0 | 0 | 0 | 0 |
| Current Assets | 3.422 | 2.993 | 2.495 | 541 | 531 | 521 | 314 | 315 | 314 | 312 |
| Inventories | 2.890 | 2.481 | 1.782 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 484 | 433 | 417 | 334 | 327 | 321 | 314 | 315 | 314 | 312 |
| Cash | 47 | 80 | 296 | 208 | 204 | 200 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -25.945 | -27.409 | -32.082 | -38.345 | -37.648 | -36.978 | -36.498 | -36.611 | -36.500 | -36.296 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 39.620 | 40.551 | 40.313 | 39.340 | 38.578 | 37.846 | 36.812 | 36.926 | 36.814 | 36.608 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Batec Biotechnologie S.r.l.